AVANIR PHARMACEUTICALS Stock Price
$4.43 
Change:
-0.19 -2.06% Volume:
166,013
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 4.725 | Todays Low: 4.425 | Open: 4.62 | Last Close: 4.61
52 Wk High: 4.77 | 52 Wk Low: 2.08 | Todays Pivot: 4.53 | Pre market open: 4.43
Sector: 
Online News For Avanir Pharmaceuticals
|
Before the Bell Scans: Dynavax Technologies, Warner Chilcott, Avanir Pharma ... - PR Newswire (press release)
Wed, 19 Jun 2013 13:02The major movers in the sector included Dynavax Technologies Corporation (NASDAQ: DVAX), Warner Chilcott Plc (NASDAQ: WCRX), Avanir Pharmaceuticals Inc. (NASDAQ: AVNR), and Actavis Inc. (NYSE: ACT). All these companies are tracked by ...
|
|
NASDAQ Decliners Watch List: Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR ... - SBWire (press release)
Wed, 19 Jun 2013 19:33Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR) a company that together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United ...
|
|
Questcor Pharmaceuticals Inc (QCOR), Avanir Pharmaceuticals, Inc. (AVNR): 3 ... - Insider Monkey (blog)
Mon, 17 Jun 2013 12:26The primary source of investor excitement stems from a Food and Drug Administration decision announced last week to allow a faster development path for AVP-786, which is basically a newer version of Avanir Pharmaceuticals, Inc. (NASDAQ:AVNR)'s ...
|
|
Why Avanir Pharmaceuticals Shares Jumped - Motley Fool
Wed, 05 Jun 2013 17:59What: Shares of Avanir Pharmaceuticals (NASDAQ: AVNR ) , a biopharmaceutical company focused on rare central nervous systems disorders, jumped as much as 13% after the Food and Drug Administration OK'd an accelerated development pathway for ...
|
|
Avanir Pharmaceuticals (NASDAQ:AVNR) Shares Set to Open Higher - Argyll Free Press
Thu, 06 Jun 2013 13:00stocks in the news Shares of Avanir Pharmaceuticals (NASDAQ:AVNR) are up in premarket trading after yesterdays announcement that the company and the FDA agreed to a faster development process for its experimental drug AVP-786 and will allow the ...
|
|
Avanir Pharmaceuticals (AVNR +4.2%) moves up today after being initiated at ... - Seeking Alpha
Fri, 14 Jun 2013 16:04Avanir Pharmaceuticals (AVNR +4.2%) moves up today after being initiated at Mizuho Securities with a Buy rating and a price target of $10 per share. The stock had a big move last week on news that the FDA has agreed to expedite the development of its ...
|
AVNR Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Avanir Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for AVNR to choose from. Visit here to build your stock quote widget »
